iSTEM Dermaceuticals

iSTEM Dermaceuticals

روّاد الأعمال

Lita Mohapatra

Lita Mohapatra

Founder & CEO

Dr. Mohapatra is a globe trotter. She has worked as a medical pract it ioner in India &Australia. She graduated as a doctor from Maharaja Krushna Chandra Gajapati Medical College. Later she pursued a double Masters in Medicine from the world renowned Universit y of Sydney, Australia. She also received a full bright scholarship from the Universit y of Newcastle, to pursue her research interest in Medicine. She has published in Nat ional &International Journals. She is also a fellow in Aesthetic Medicine and Cosmetology. She has also received a Doctorate in Dermatology, Dlitt in Dermatology (Hon) from USA. She was also featured in Forbes India, London Daily Post, India Saga, ANI, Business Standard, Outlook, Times of India and 1000 plus portals nat ionally and internationally acclaiming and recognizing her journey as a women entrepreneur & doctor.
K 0 $

  • iSTEM Dermaceuticals has joined FasterCapital's portfolio.
  • We help startups in building their product, increasing sales, entering new markets, finding investors, and writing and preparing their documents.
  • Entrepreneurs can join our main programs; Tech Cofounder, Grow your Startup, Idea to Product, or Raise Capital.

Idea

iSTEM Dermaceuticals is pioneering a regenerative, sustainable, and toxin-free revolution in beauty by replacing conventional fossil-fuel-derived, chemical-laden cosmetics with botanically powered, science-driven dermaceutical innovations. The company is built on the belief that skincare should be safe, ethical, inclusive, and planet-positive—free from microplastics, endocrine disruptors, and carcinogenic contaminants. Fueled by green chemistry and blue-beauty principles, iSTEM envisions a new era where high-performance skincare nurtures both people and the planet.

Challenge

iSTEM Dermaceuticals is tackling the alarming rise of toxic beauty practices, greenwashing, microplastic pollution, and chemical exposure that threaten skin health, reproductive health, and long-term cancer risk. The brand is responding to public distrust, rising complaints, and global lawsuits associated with harmful cosmetic ingredients by delivering truly fossil-free, non-toxic, clinically validated alternatives. Their mission directly confronts industry gaps in safety, sustainability, transparency, and ethical production—areas where consumers are demanding radical change.

Solution

iSTEM Dermaceuticals is developing a breakthrough portfolio of next-generation skin therapeutics and dermaceutical formulations powered by phytostem cells, nanospheres, 3D dissolvable micro-needle systems, and fossil-free bio-derived ingredients. With seven proprietary products in the pipeline—supported by patented nanotechnology, hyperpigmentation treatment systems, and sustainable bioprocess engineering—the company offers safe, effective, and globally scalable solutions manufactured through a robust R&D ecosystem in India and Europe.


Are you interested in investing in iSTEM Dermaceuticals?


Let us know!

برامجنا

تأمين رأس المال

نساعد الشركات الناشئة على جمع التمويل من خلال التواصل مع المصتثمرين المناسبين وتقديم دعم وخدمات متكاملة

تمويل مشاريع ضخمة

حلول تمويل واسعة النطاق للشركات الناشئة والشركات ذات إمكانيات النمو الكبيرة.

الشريك التقني

نصبح الشريك المؤسس التقني لشركتك، ونتولى تطوير المنتج ونقدم خبرات تقنية استراتيجية.

حسّن مبيعاتك

قم بتوسيع أعمالك من خلال استراتيجيات وموارد وشراكات تركز على النمو.

من فكرة إلى منتج

حوّل أفكارك المبتكرة إلى منتجات مكتملة وجاهزة للسوق بمساعدتنا المتخصصة.

تمويل مشاريع الإعمار

حلول تمويل شاملة مصممة خصيصًا للشركات الناشئة والشركات العاملة في قطاع العقارات.

فرانتشايز للشركات

استكشف فرص الامتياز التجاري وقم بتطوير أعمالك ضمن نموذج عمل مُثبت.

حقوق الملكية الفكرية

احمِ حقوق الملكية الفكرية الخاصة بك مع توجيه خبراء في براءات الاختراع والعلامات التجارية وحقوق النشر والمزيد.

بدء شركة في الإمارات

نحن نساعدك في تأسيس عملك في الإمارات من خلال حلول مخصصة، دعم قانوني، واستراتيجيات دخول إلى السوق.

أخبار iSTEM Dermaceuticals (1)

FasterCapital backs iSTEM dermaceuticals to accelerate green cosmeceutical innovation
26 Nov 2025

FasterCapital backs iSTEM dermaceuticals to accelerate green cosmeceutical innovation

New Delhi, India & Dubai, UAE- Nov 2025

iSTEM Dermaceuticals and FasterCapital today announced a strategic partnership through FasterCapital’s Equitypilot program to accelerate commercialization of iSTEM’s fossil-fuel-free, phytochemical-based skin therapeutics across APAC and global markets. The collaboration pairs iSTEM’s R&D and patented nano-encapsulation technology with FasterCapital’s global acceleration, capital and go-to-market expertise.

Market opportunity & problem statement

The global natural and organic cosmetics market is projected to surpass $29.9 billion by 2027, while mainstream cosmeticeuticals remain heavily reliant on fossil-derived ingredients, microplastics and endocrine-disrupting chemicals. Consumers and regulators are demanding safer, transparent alternatives. iSTEM targets this white space with therapeutics addressing pigmentation, dysbiosis and sustainable delivery systems — a category with strong growth in North America and APAC and limited truly fossil-fuel-free, clinical-stage entrants.

Startup solution & differentiation

iSTEM dermaceuticals combines patented nano-encapsulated phytostem cell extracts and a 3D self-dissolvable micro-needle hyperpigmentation system to deliver clinically superior efficacy with reduced toxic burden. Key IP includes a nano-encapsulation platform, a 3D dissolvable delivery system and a bio-based 1,3-PDO production method. Current pipeline: a phytostem cell serum advancing to clinical trials, a double-booster serum in dermatological testing, and prototype micro-needle patches. Manufactured in Europe with formulations developed in India, iSTEM presents defensible tech, COSMOS-style sustainability credentials, and early GMP manufacturing and distribution collaborations in the GCC.

FasterCapital partnership value

Through Equitypilot, FasterCapital will provide iSTEM with structured fundraising support, product-market fit optimization, industry introductions, regulatory strategy, and international GTM capabilities. FasterCapital’s selective investment criteria and global mentor network validate iSTEM’s scientific rigor and market potential. The partnership targets clinical milestone delivery, regulatory clearance roadmap, and a 12–24 month scale-up timeline to reach retail and dermaceutical channels.

Executive quotes

“Hesham Zreik and the FasterCapital team back startups that combine technical defensibility with global market potential. iSTEM’s fossil-fuel-free platform and clinical-forward pipeline fit that thesis, and Equitypilot will fast-track their path from prototype to market,” said Hesham Zreik, investor and advisor.

“We founded iSTEM to eliminate toxic, fossil-derived ingredients from effective skin therapeutics. FasterCapital’s Equitypilot gives us the capital access, commercialization expertise and global reach to bring safe, sustainable dermaceuticals to millions,” said Dr. Lita Mohapatra, CEO & Founder, iSTEM dermaceuticals.

Growth trajectory & future plans

Near-term priorities include completing clinical trials for the phytostem serum, dermatological clearance of the booster serum, and pilot commercialization of multi-unit micro-needle patches. iSTEM aims to scale manufacturing, secure retail and dermaceutical distribution partnerships across APAC and North America, and pursue a Series A within 12–18 months to fund global expansion.

About iSTEM dermaceuticals

iSTEM dermaceuticals pioneers fossil-fuel-free cosmeceuticals using phytochemicals, oleochemicals and nano-encapsulation to deliver safe, effective skin therapeutics. Headquartered in India with European manufacturing, the company advances clinically-driven products to replace toxic cosmetic ingredients and microplastics.

About FasterCapital

FasterCapital is a global venture builder and online incubator dedicated to co-funding and co-founding innovative startups. Established in 2014, we are now #1 venture builder in terms of number of startups that we have helped, money invested and money raised. It supports startups worldwide through various programs, including funding assistance, business development, and technical support. The Equitypilot program is designed to help early-stage startups build scalable solutions with mentorship, strategic guidance, and network support.

أرسل بريد إلكتروني!